StreetInsider.com  Mar 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+Pharma+%28JAZZ%29%2C+Gentium+Launch+Defitelio+in+Europe/9331698.html for the full story.
StreetInsider.com  Feb 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+Pharmaceuticals+%28JAZZ%29+CFO+Resigns%2C+Replacement+Named/9214482.html for the full story.
StreetInsider.com  Feb 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Jazz+Pharmaceuticals%2C+Inc.+%28JAZZ%29+Misses+Q4+EPS+by+6c%2C+Offers+Guidance/9214469.html for the full story.
SeekingAlpha  Feb 5  Comment 
By Shawn Arshad: Jazz Pharmaceuticals PLC (JAZZ), a mid-cap Pharma equity based in Ireland has been a very successful trade on NASDAQ since 2007. The company specializes in narcolepsy, oncology, psychiatry, and Parkinson's treatment. Since 2007,...
StreetInsider.com  Dec 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+Pharma+%28JAZZ%29+to+Acquire+Gentium+%28GENT%29+for+%2457Share/8997214.html for the full story.
Market Intelligence Center  Dec 17  Comment 
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Jazz Pharmaceuticals Inc. (JAZZ) today after it closed at $112.19 on Monday. For more conservative...
Market Intelligence Center  Nov 21  Comment 
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Jazz Pharmaceuticals Inc. (JAZZ) that should provide a 6.12% return in just 58 days. Buy one Jan....
Market Intelligence Center  Nov 19  Comment 
Monday’s trading in Jazz Pharmaceuticals Inc. (JAZZ) gives options traders an opportunity for a 5.26% return. By selling the Jan. '14 $105.00 call and buying the Jan. '15 call at the $45.00 level for a net debit of $57.00, traders will book a...
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Jazz+Pharmaceuticals%2C+Inc.+%28JAZZ%29+Tops+Q3+EPS+by+11c%3B+Issues+Solid+Oultook/8848419.html for the full story.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki